Short Interest in Hologic, Inc. (NASDAQ:HOLX) Grows By 71.7%

Hologic, Inc. (NASDAQ:HOLX) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 8,301,510 shares, a growth of 71.7% from the February 12th total of 4,834,145 shares. Currently, 3.8% of the company’s shares are sold short. Based on an average daily trading volume, of 2,180,670 shares, the days-to-cover ratio is presently 3.8 days. Based on an average daily trading volume, of 2,180,670 shares, the days-to-cover ratio is presently 3.8 days. Currently, 3.8% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. BNP Paribas Exane downgraded shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 target price on the stock. in a research note on Friday, November 21st. Argus downgraded shares of Hologic from a “buy” rating to a “hold” rating in a report on Monday, January 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Hologic in a research report on Wednesday, January 28th. Finally, Evercore lowered Hologic from an “outperform” rating to an “in-line” rating and dropped their target price for the company from $79.00 to $78.00 in a research report on Monday, January 5th. Two investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $78.42.

Hologic Trading Down 0.0%

HOLX traded down $0.03 on Friday, reaching $75.19. 2,331,740 shares of the company traded hands, compared to its average volume of 2,554,059. The company has a market cap of $16.78 billion, a P/E ratio of 31.33, a price-to-earnings-growth ratio of 2.24 and a beta of 0.73. The company has a quick ratio of 3.32, a current ratio of 4.04 and a debt-to-equity ratio of 0.48. Hologic has a one year low of $51.90 and a one year high of $75.75. The firm has a fifty day simple moving average of $75.12 and a two-hundred day simple moving average of $72.58.

Hologic (NASDAQ:HOLX) last issued its earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 EPS for the quarter, missing analysts’ consensus estimates of $1.09 by ($0.05). The company had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Hologic had a return on equity of 19.58% and a net margin of 13.18%.The business’s revenue was up 2.5% compared to the same quarter last year. During the same period last year, the business posted $0.87 earnings per share. As a group, equities research analysts expect that Hologic will post 4.28 earnings per share for the current year.

Hedge Funds Weigh In On Hologic

Several institutional investors and hedge funds have recently added to or reduced their stakes in HOLX. The Manufacturers Life Insurance Company boosted its holdings in shares of Hologic by 294.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,022,455 shares of the medical equipment provider’s stock valued at $718,223,000 after buying an additional 8,227,318 shares in the last quarter. HBK Investments L P acquired a new stake in Hologic in the fourth quarter valued at approximately $625,716,000. Invesco Ltd. lifted its holdings in shares of Hologic by 72.5% during the 2nd quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock valued at $543,486,000 after purchasing an additional 3,505,828 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Hologic by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 5,919,013 shares of the medical equipment provider’s stock worth $439,228,000 after purchasing an additional 22,019 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its position in shares of Hologic by 2.6% in the 4th quarter. Victory Capital Management Inc. now owns 5,609,912 shares of the medical equipment provider’s stock worth $417,882,000 after purchasing an additional 139,867 shares in the last quarter. Hedge funds and other institutional investors own 94.73% of the company’s stock.

Hologic Company Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.